NCT04141371View on ClinicalTrials.gov

Molar Sodium Lactate Filling in Severe Meningeal Hemorrhage

PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

May 5, 2022

Study Completion Date

June 7, 2024

Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
DRUG

Molar Sodium Lactate

daily 3-hour infusion of sodium molar lactate during the vasospasm period

DRUG

physiological serum

daily saline infusion over 3 hours during the vasospasm period

Trial Locations (3)

13000

Marseille Hospital, Marseille

Unknown

Grenoble Hospital, Grenoble

06000

Carole ICHAI, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER